known allergies; blood-typing; and HIV (HTLV III) testing. The recordings will be continued on the current record until additional space is required under any single category. In such cases, a new SF 601 will be inserted and retained with the old SFs 601. Concurrently, a thorough verification of the entries will be made and all immunizations brought up to date. Replacement of the current SF 601 is not required for a change in grade, rating, or status of the member. When the health record is closed, all SFs 601 are forwarded together with other parts of the health record.
The name of the medical officer or Medical Department representative administering the immunization or test or determining the nature of the sensitivity reaction will be typed or stamped on the form. Signatures are not required; however, in the event of their use, care should be taken to ensure their legibility.
The medical officer or Medical Department representative administering the immunization is responsible for completing all entries in the appropriate sections of SF 601. For specific immunizing agents for smallpox, cholera, and yellow fever, the manufacturer’s name and batch or lot number must be recorded.
Entries concerning a determined hypersensitivity to a drug or chemical are typed under “Remarks and Recommendations” in capitals (e.g., HYPERSENSITIVY TO ASPIRIN, HYPERSENSITIVE TO LIDOCAINE). This is in addition to a similar entry required on the SF 603 and SF 600, SPECIAL-HYPERSENSITIVITY, retained permanently in the health record.
When recording positive results (10 mm or more induration) of the tuberculin skin test (PPD), see BUMEDINST 6224.1 series for current procedures for the Tuberculosis Control Program.
When recording the results of the HIV (HTLV III) test, the documentation will include the date drawn, the type of test (ELISA/Western Blot), and the results (positive or negative).
All personnel performing international travel under the cognizance of the Department of the Navy will be immunized in accordance with BUMEDINST 6320 series and the current edition of NAVMED P-5052.15A and have in their possession a properly completed and authenticated PHS Form 731, International Certificate of Immunization.
Syphilis Record (SF 602)
A separate SF 602 (Figs. 10-8 and 10-8A) is prepared upon the occurrence of a syphilitic infection, including any complication or sequels. This record remains a permanent part of the health record until the health record is closed. This procedure is applicable regardless of whether or not more than one SF 602 is required during the member’s term of service. An entry will be made of each leutic examination or test conducted and each course of treatment given. Essentially the form is self-explanatory. Abbreviations used in recording treatment should be those officially recognized, Letter designations should not be used for the medications administered.
In section I of the form, list all past sexually transmitted diseases, using only the official nomenclature.
In section II, the patient signs the form, indicating that he or she understands the nature of the disease and its treatment. Any discussion with patients concerning their condition and health should be accomplished in private, and the information should be considered privileged.
Abstract of Service and Medical History (NAVMED 6150/4)
This form provides a chronological history of ships and stations to which a member has been assigned for duty and treatment and an abstract of medical history for each admission to the sicklist.
A NAVMED 6150/4 (fig. 10-9) is prepared upon opening the health record, and it remains with the health record regardless of any change in the member’s status. Continuation sheets are incorporated whenever a current abstract is completely filled.
The form is self-explanatory:
1. Ship or Station— Enter the name of the ship or station to which the member is attached for duty or treatment.
2. Diagnosis, Diagnosis Number, and Remarks—Enter the reason why the individual is attached to the activity listed in the Ship or Station column, such as “Duty,” “Treatment,” and “FFT.” Enter the diagnosis title and ICDA number each time final disposition from the sicklist is made. When there is more than one diagnosis for a single admission, record each diagnosis.
